| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Aveanna Healthcare (AVAH) Just Ended A Four-Year Rate Fight | 1 | Insider Monkey | ||
| Fr | Aveanna Healthcare Aktie erreicht Rekordhoch von 13,44 USD | 4 | Investing.com Deutsch | ||
| AVEANNA HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| Fr | Aktienplatzierung durch Großaktionäre setzt Aveanna Healthcare unter Druck | 4 | Investing.com Deutsch | ||
| Fr | Aveanna Healthcare prices 15M share secondary offering at $11.75 per share | 1 | Seeking Alpha | ||
| Fr | Aveanna Healthcare prices 15 million share secondary offering | 2 | Investing.com | ||
| Fr | Aveanna Healthcare Holdings, Inc: Aveanna Announces Pricing of Secondary Offering of Common Stock | 1 | GlobeNewswire (USA) | ||
| Do | Sekundärplatzierung belastet Aveanna Healthcare Aktie | 3 | Investing.com Deutsch | ||
| Do | Aveanna Healthcare Holdings, Inc: Aveanna Announces Launch of Secondary Offering of Common Stock | 2 | GlobeNewswire (USA) | ||
| 14.08. | AVAH Q2 Earnings Call Highlights Higher Growth Targets | 1 | Zacks | ||
| 14.08. | Raymond James raises Aveanna Healthcare stock price target on strong results | 1 | Investing.com | ||
| 14.08. | Starke Ergebnisse: Raymond James hebt Kursziel für Aveanna Healthcare an | 1 | Investing.com Deutsch | ||
| 14.08. | Top Biotech Gainers: HCTI, LEXX, LNSR, JUNS, OMER, AVAH... | 6 | RTTNews | ||
| 14.08. | Biotech Stocks At 52-Week Highs - PARK +10%, AVAH +24%, CADL +10% On Q2 Reports, LH, COAG | 823 | AFX News | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| 14.08. | Aveanna hits 52-week high after Q2 beat, guidance hike | 2 | Seeking Alpha | ||
| 13.08. | Aveanna Healthcare: Aktie steigt nach übertroffenen Umsatzerwartungen und erhöhter Jahresprognose | 1 | Investing.com Deutsch | ||
| 13.08. | Aveanna Healthcare Holdings Non-GAAP EPS of $0.22 beats by $0.05, revenue of $670.48M beats by $31.85M | 1 | Seeking Alpha | ||
| 13.08. | Aveanna Healthcare Holdings, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 12.08. | Aveanna Healthcare Holdings Q2 2026 Earnings Preview | 2 | Seeking Alpha | ||
| 10.08. | Will Lower PDS Margin Affect Aveanna Healthcare's Q2 Earnings? | 1 | Zacks | ||
| 10.08. | Is the Options Market Predicting a Spike in Aveanna Healthcare Stock? | 1 | Zacks |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SENSUS HEALTHCARE | 2,520 | -10,64 % | Sensus Healthcare, Inc. - 10-Q, Quarterly Report | ||
| FRESENIUS MEDICAL CARE | 40,140 | -1,83 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| FRESENIUS | 46,600 | +0,83 % | EQS-News: Fresenius SE & Co. KGaA: Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen Euro | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Beteiligung/Unternehmensbeteiligung
Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 40,200 | +0,98 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| HEARTFLOW | 49,750 | 0,00 % | Heartflow Aktie auf Rekordhoch: Kurs steigt auf 48,7 USD | ||
| LIFESTANCE HEALTH GROUP | 12,470 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| PROGYNY | 25,650 | 0,00 % | Progyny, Inc. Announces Second Quarter 2026 Results | Reports Record Quarterly Revenue, Gross Profit and Adjusted EBITDARobust Selling Season Activity Continues to Reflect Strong Demand for Women's Health, Family Building SolutionsValue Returned to Shareholders... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 58,84 | -0,05 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| BILLIONTOONE | 95,20 | +0,18 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 32,480 | +1,06 % | Milliardenmarkt Augengesundheit: Warum EssilorLuxottica und Carl Zeiss Meditec auf neue Technologien setzen - und wo Rise Nano Optics ins Spiel kommt | ||
| GENEDX | 87,05 | 0,00 % | GeneDx launches online exome testing for pediatric patients | ||
| ALIGNMENT HEALTHCARE | 13,165 | +0,04 % | Alignment Healthcare files motion to dismiss whistleblower lawsuit | ||
| SANARA MEDTECH | 34,430 | -0,06 % | Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) | FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. ("Sanara," "Sanara MedTech," the "Company," "we," "our" or "us") (Nasdaq: SMTI), a medical technology company focused on developing... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,120 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 21,670 | -0,05 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen |